Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Diabetes

  Free Subscription


15.04.2024

1 Acta Ophthalmol
1 Am J Clin Nutr
1 Am J Manag Care
1 Atherosclerosis
1 Biochem Biophys Res Commun
3 BMC Ophthalmol
1 BMC Pediatr
1 BMJ
1 Circulation
3 Diabet Med
3 Diabetes
2 Diabetes Care
18 Diabetes Obes Metab
2 Diabetologia
5 J Am Coll Cardiol
3 J Clin Endocrinol Metab
3 J Diabetes Complications
1 J Immunol
1 JAMA
1 Minerva Pediatr (Torino)
3 N Engl J Med
2 Nature
1 Ophthalmol Retina
1 Pediatr Diabetes
1 PLoS Med
9 PLoS One
1 Proc Natl Acad Sci U S A
1 WMJ


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Ophthalmol

  1. HATAMNEJAD A, Orr S, Dadak R, Khanani A, et al
    Anti-VEGF and steroid combination therapy relative to anti-VEGF mono therapy for the treatment of refractory DME: A systematic review of efficacy and meta-analysis of safety.
    Acta Ophthalmol. 2024;102:e204-e214.
    PubMed         Abstract available


    Am J Clin Nutr

  2. CHEN F, Mangano KM, Garelnabi M, Cardaleen K, et al
    Associations Among Diabetes Medication Use, Serum Magnesium, and Insulin Resistance in a Cohort of Older Puerto Rican Adults.
    Am J Clin Nutr. 2024 Apr 8:S0002-9165(24)00395.
    PubMed         Abstract available


    Am J Manag Care

  3. CHOE JH, Xuan S, Goldenberg A, Matian J, et al
    Medication persistence and its impact on type 2 diabetes.
    Am J Manag Care. 2024;30:e124-e134.
    PubMed         Abstract available


    Atherosclerosis

  4. DING X, Qiu Y, Wu G, Li S, et al
    l-thyroxine attenuates extracellular Hsp90alpha-induced vascular endothelial calcification in diabetes mellitus, as revealed by parallel metabolic profiles.
    Atherosclerosis. 2024;392:117527.
    PubMed         Abstract available


    Biochem Biophys Res Commun

  5. FUKUDA Y, Okada H, Tomita H, Suzuki K, et al
    Nafamostat mesylate decreases skin flap necrosis in a mouse model of type 2 diabetes by protecting the endothelial glycocalyx.
    Biochem Biophys Res Commun. 2024;710:149843.
    PubMed         Abstract available


    BMC Ophthalmol

  6. CHEN S, Li Y, Song W, Cheng Y, et al
    Insulin eye drops improve corneal wound healing in STZ-induced diabetic mice by regulating corneal inflammation and neuropeptide release.
    BMC Ophthalmol. 2024;24:155.
    PubMed         Abstract available

  7. RANI PK
    Management of diabetic ocular complications: from cellular insights to community strategies.
    BMC Ophthalmol. 2024;24:151.
    PubMed         Abstract available

  8. LEE CY, Park JM, Yeom MI
    Risk factors of internal carotid artery stenosis in patients with proliferative diabetic retinopathy: an analysis using optical coherence tomography and optical coherence tomography angiography.
    BMC Ophthalmol. 2024;24:156.
    PubMed         Abstract available


    BMC Pediatr

  9. ALMAHMOUD R, Hussein A, Khaja FA, Soliman AF, et al
    Growth and endocrinopathies among children with beta-Thalassemia major treated at Dubai Thalassemia centre.
    BMC Pediatr. 2024;24:244.
    PubMed         Abstract available


    BMJ

  10. BOKINNI Y
    Barbados is in the grip of a diabetic foot amputation crisis.
    BMJ. 2024;385:q350.
    PubMed        


    Circulation

  11. BLOOD AJ, Chang LS, Hassan S, Chasse J, et al
    Randomized Evaluation of a Remote Management Program to Improve Guideline-directed Medical Therapy: The Diabetes Remote Intervention to Improve Use of Evidence-based Medications (DRIVE) Trial.
    Circulation. 2024 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.069494.
    PubMed         Abstract available


    Diabet Med

  12. DE VRIES M, Westerink J, Kaasjager HAH, de Valk HW, et al
    Association of physical activity and sports participation with insulin resistance and non-alcoholic fatty liver disease in people with type 1 diabetes.
    Diabet Med. 2024 Apr 8:e15317. doi: 10.1111/dme.15317.
    PubMed         Abstract available

  13. HEALD A, Lu W, Robinson A, Schofield H, et al
    Mortality in people with a diabetes foot ulcer: An update from the Salford podiatry clinic follow-up study.
    Diabet Med. 2024 Apr 9:e15328. doi: 10.1111/dme.15328.
    PubMed        

  14. SU R, Whitmore C, Alliston P, Tanzini E, et al
    Demystifying diabetes health coaching: A scoping review unveiling the 'who' and 'where' of health coaching for adults with type 2 diabetes.
    Diabet Med. 2024 Apr 10:e15327. doi: 10.1111/dme.15327.
    PubMed         Abstract available


    Diabetes

  15. YAMATO M, Kato N, Yamada KI, Inoguchi T, et al
    The Early Pathogenesis of Diabetic Retinopathy and Its Attenuation by Sodium-Glucose Transporter 2 Inhibitors.
    Diabetes. 2024 Apr 12:db220970. doi: 10.2337/db22-0970.
    PubMed         Abstract available

  16. LI Y, Chen GC, Moon JY, Arthur R, et al
    Genetic subtypes of prediabetes, healthy lifestyle, and risk of type 2 diabetes.
    Diabetes. 2024 Apr 11:db230699. doi: 10.2337/db23-0699.
    PubMed         Abstract available

  17. ASTRADA A
    Comment on Pataky et al. Divergent Skeletal Muscle Metabolomic Signatures of Different Exercise Training Modes Independently Predict Cardiometabolic Risk Factors. Diabetes 2024;73:23-37.
    Diabetes. 2024 Apr 9:db240033. doi: 10.2337/db24-0033.
    PubMed        


    Diabetes Care

  18. YANG PK, Jackson SL, Charest BR, Cheng YJ, et al
    Type 1 Diabetes Genetic Risk in 109,954 Veterans With Adult-Onset Diabetes: The Million Veteran Program (MVP).
    Diabetes Care. 2024 Apr 12:dc231927. doi: 10.2337/dc23-1927.
    PubMed         Abstract available

  19. SHI S, Dong Y, Wang S, Du X, et al
    Associations of Dietary Cholesterol Consumption With Incident Diabetes and Cardiovascular Disease: The Role of Genetic Variability in Cholesterol Absorption and Disease Predisposition.
    Diabetes Care. 2024 Apr 9:dc232336. doi: 10.2337/dc23-2336.
    PubMed         Abstract available


    Diabetes Obes Metab

  20. TAN YH, Tan WL, Eichinger V, Ruch B, et al
    Blood glucose control using a mobile health application in Singapore, Philippines and Hong Kong: a retrospective real-world data analysis.
    Diabetes Obes Metab. 2024;26:1990-1992.
    PubMed        

  21. THIRUMALAI A, Chao JH, Kaleru T, Dong X, et al
    Bridging dose of U-100 glargine with first dose of insulin degludec improves glycaemia in the 48 h after transition in twice-daily glargine users.
    Diabetes Obes Metab. 2024;26:1868-1876.
    PubMed         Abstract available

  22. SIMON SL, Snell-Bergeon JK, Schafer M, Barker AJ, et al
    Sleep duration and association with cardiometabolic health in adolescents and adults with type 1 diabetes: Results from the BCQR-T1D study.
    Diabetes Obes Metab. 2024 Apr 8. doi: 10.1111/dom.15582.
    PubMed         Abstract available

  23. VERNSTROM L, Gullaksen S, Sorensen SS, Funck KL, et al
    Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial.
    Diabetes Obes Metab. 2024;26:1624-1635.
    PubMed         Abstract available

  24. WU Y, Zhang C, Duan S, Li Y, et al
    TEAD1, MYO7A and NDUFC2 are novel functional genes associated with glucose metabolism in BXD recombinant inbred population.
    Diabetes Obes Metab. 2024;26:1775-1788.
    PubMed         Abstract available

  25. SALERNO PRVO, Qian A, Dong W, Deo S, et al
    County-level socio-environmental factors and obesity prevalence in the United States.
    Diabetes Obes Metab. 2024;26:1766-1774.
    PubMed         Abstract available

  26. IRLIK K, Aldosari H, Hendel M, Kwiendacz H, et al
    Artificial intelligence-enhanced electrocardiogram analysis for identifying cardiac autonomic neuropathy in patients with diabetes.
    Diabetes Obes Metab. 2024 Apr 11. doi: 10.1111/dom.15578.
    PubMed         Abstract available

  27. GRANDO ALVES G, Cunha L, Henkes Machado R, Lins de Menezes V, et al
    Safety and efficacy of teplizumab in the treatment of type 1 diabetes mellitus: An updated systematic review and meta-analysis of randomized controlled trials.
    Diabetes Obes Metab. 2024 Apr 11. doi: 10.1111/dom.15581.
    PubMed         Abstract available

  28. GUO L, Tian F, Liu L, Chen M, et al
    Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial.
    Diabetes Obes Metab. 2024 Apr 11. doi: 10.1111/dom.15601.
    PubMed         Abstract available

  29. GUO L, Xi Y, Li L, Guo K, et al
    Real-world treatment satisfaction with dulaglutide, and its influencing factors, in a Chinese population with type 2 diabetes mellitus.
    Diabetes Obes Metab. 2024 Apr 10. doi: 10.1111/dom.15590.
    PubMed        

  30. LASSEN MCH, Johansen ND, Modin D, Nealon J, et al
    Effects of high-dose versus standard-dose quadrivalent influenza vaccine among patients with diabetes: A post-hoc analysis of the DANFLU-1 trial.
    Diabetes Obes Metab. 2024;26:1821-1829.
    PubMed         Abstract available

  31. SAID F, Arnott C, Voors AA, Heerspink HJL, et al
    Prediction of new-onset heart failure in patients with type 2 diabetes derived from ALTITUDE and CANVAS.
    Diabetes Obes Metab. 2024 Apr 8. doi: 10.1111/dom.15592.
    PubMed         Abstract available

  32. YEW MJ, Heywood SE, Ng J, West OM, et al
    ACAD10 is not required for metformin's metabolic actions or for maintenance of whole-body metabolism in C57BL/6J mice.
    Diabetes Obes Metab. 2024;26:1731-1745.
    PubMed         Abstract available

  33. GILBERT MP, Skelly J, Hernandez AF, Green JB, et al
    Effect of albiglutide on cardiovascular outcomes in older adults: A post hoc analysis of a randomized controlled trial.
    Diabetes Obes Metab. 2024;26:1714-1722.
    PubMed         Abstract available

  34. DIALLO A, Diallo MF, Carlos-Bolumbu M, Galtier F, et al
    Uric acid-lowering effects of sodium-glucose cotransporter 2 inhibitors for preventing cardiovascular events and mortality: A systematic review and meta-analysis.
    Diabetes Obes Metab. 2024;26:1980-1985.
    PubMed         Abstract available

  35. CHAN SY, Zhang H, Wong JT, Chang HF, et al
    Higher early pregnancy plasma myo-inositol associates with increased postprandial glycaemia later in pregnancy: Secondary analyses of the NiPPeR randomized controlled trial.
    Diabetes Obes Metab. 2024;26:1658-1669.
    PubMed         Abstract available

  36. DE GERMAY S, Pambrun E, Pariente A, Grenet G, et al
    Use of sodium-glucose cotransporter-2 inhibitors in France: Analysis of French nationwide health insurance database.
    Diabetes Obes Metab. 2024;26:1678-1686.
    PubMed         Abstract available

  37. SOURIJ C, Oulhaj A, Aziz F, Tripolt NJ, et al
    Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post-hoc analysis of the EMMY trial.
    Diabetes Obes Metab. 2024;26:1971-1975.
    PubMed        


    Diabetologia

  38. ELEFTHERIADOU A, Riley D, Zhao SS, Austin P, et al
    Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: a real-world data study from a global federated database.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06132.
    PubMed         Abstract available

  39. VALABHJI J, Holman N, Collins N, Young RJ, et al
    Can the introduction of a 12-lead ECG help reduce mortality in those presenting with foot ulceration to multidisciplinary diabetic foot clinics? An observational evaluation of a real-world implementation pilot in England.
    Diabetologia. 2024 Apr 8. doi: 10.1007/s00125-024-06134.
    PubMed         Abstract available


    J Am Coll Cardiol

  40. NEIJENHUIS RML, MacDonald ST, Zemrak F, Mertens BJA, et al
    Effect of Sodium-Glucose Cotransporter 2 Inhibitors in Adults With Congenital Heart Disease.
    J Am Coll Cardiol. 2024;83:1403-1414.
    PubMed         Abstract available

  41. JANUZZI JL JR, Butler J, Del Prato S, Ezekowitz JA, et al
    Randomized Trial of a Selective Aldose Reductase Inhibitor in Patients With Diabetic Cardiomyopathy.
    J Am Coll Cardiol. 2024 Apr 3:S0735-1097(24)06613.
    PubMed         Abstract available

  42. MARTON A, Saffari SE, Rauh M, Sun RN, et al
    Water Conservation Overrides Osmotic Diuresis During SGLT2 Inhibition in Patients With Heart Failure.
    J Am Coll Cardiol. 2024;83:1386-1398.
    PubMed         Abstract available

  43. PACKER M
    SGLT2 Inhibition: Neither a Diuretic nor a Natriuretic.
    J Am Coll Cardiol. 2024;83:1399-1402.
    PubMed        

  44. BURCHILL LJ, Jain CC, Miranda WR
    Advancing New Solutions for Adult Congenital Heart Disease-Related Heart Failure.
    J Am Coll Cardiol. 2024;83:1415-1417.
    PubMed        


    J Clin Endocrinol Metab

  45. MOON S, Lee M, Lee JS, Lee J, et al
    Association between hypotension during pancreatectomy and development of postoperative diabetes.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae227. doi: 10.1210.
    PubMed         Abstract available

  46. PIEMONTE E, Bruzzaniti S, Galgani M
    Type 2 Diabetes: Fighting Inflammation Fire of T lymphocytes with Magnesium.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae231. doi: 10.1210.
    PubMed        

  47. LI L, Ji W, Wang Z, Cheng Y, et al
    Air pollution and diabetes mellitus: Association and validation in a desert area in China.
    J Clin Endocrinol Metab. 2024 Apr 9:dgae219. doi: 10.1210.
    PubMed         Abstract available


    J Diabetes Complications

  48. GRACIA-RAMOS AE, Cruz-Dominguez MDP, Madrigal-Santillan EO, Rojas-Martinez R, et al
    Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial.
    J Diabetes Complications. 2024;38:108742.
    PubMed         Abstract available

  49. FARAH R, Alhajahjeh A, Al-Farahid O, Abuzaid H, et al
    Risk factors for chronic kidney disease in middle eastern patients with type 2 diabetes mellitus: A cross-sectional study using the KDIGO classification.
    J Diabetes Complications. 2024;38:108740.
    PubMed         Abstract available

  50. PINES-CORRALES PJ, Lopez-Garcia MC, Sanz-Velasco A, Moya-Moya AJ, et al
    Changes in glucometric parameters in people living with diabetes users of the free-style libre 2 system before and after the update possibility to real-time glucose readings in real world practice.
    J Diabetes Complications. 2024;38:108723.
    PubMed         Abstract available


    J Immunol

  51. DE GEORGE DJ, Jhala G, Selck C, Trivedi P, et al
    Altering beta Cell Antigen Exposure to Exhausted CD8+ T Cells Prevents Autoimmune Diabetes in Mice.
    J Immunol. 2024 Apr 8:ji2300785. doi: 10.4049/jimmunol.2300785.
    PubMed         Abstract available


    JAMA

  52. RUBIN R
    All of Us Program Illustrates What Less-Diverse Genomics Studies Might Be Missing.
    JAMA. 2024;331:1167-1168.
    PubMed        


    Minerva Pediatr (Torino)

  53. CATASSI C, Vincentini O, Pricci F, Agrimi U, et al
    Pediatric screening for type 1 diabetes and celiac disease: the future is today in Italy.
    Minerva Pediatr (Torino). 2024 Apr 10. doi: 10.23736/S2724-5276.24.07573.
    PubMed        


    N Engl J Med

  54. KOSIBOROD MN, Petrie MC, Borlaug BA, Butler J, et al
    Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes.
    N Engl J Med. 2024 Apr 6. doi: 10.1056/NEJMoa2313917.
    PubMed         Abstract available

  55. VAZQUEZ MA, Oliver G, Amarasingham R, Sundaram V, et al
    Pragmatic Trial of Hospitalization Rate in Chronic Kidney Disease.
    N Engl J Med. 2024;390:1196-1206.
    PubMed         Abstract available

  56. MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH
    Prevention of Cardiovascular Disease in Type 1 Diabetes.
    N Engl J Med. 2024;390:1207-1217.
    PubMed        


    Nature

  57. GRAHAM F
    Daily briefing: Diabetes drug shows promise against Parkinson's.
    Nature. 2024 Apr 5. doi: 10.1038/d41586-024-01049.
    PubMed        


  58. Genetic risk variants lead to type 2 diabetes development through different pathways.
    Nature. 2024 Apr 10. doi: 10.1038/d41586-024-00440.
    PubMed        


    Ophthalmol Retina

  59. VUJOSEVIC S, Alovisi C, Piccoli G, Brambilla M, et al
    Severity of Disorganization of Retinal Layers and Visual Function Impairment in Diabetic Retinopathy.
    Ophthalmol Retina. 2024 Apr 9:S2468-6530(24)00179.
    PubMed         Abstract available


    Pediatr Diabetes

  60. SRINIVASAN S, Chen L, Udler M, Todd J, et al
    Initial Insights into the Genetic Variation Associated with Metformin Treatment Failure in Youth with Type 2 Diabetes.
    Pediatr Diabetes. 2023;2023:8883199.
    PubMed         Abstract available


    PLoS Med

  61. SHI M, Yang A, Lau ESH, Luk AOY, et al
    A novel electronic health record-based, machine-learning model to predict severe hypoglycemia leading to hospitalizations in older adults with diabetes: A territory-wide cohort and modeling study.
    PLoS Med. 2024;21:e1004369.
    PubMed         Abstract available


    PLoS One

  62. SAAD EA, Hassan HA, Ghoneum MH, Alaa El-Dein M, et al
    Edible wild plants, chicory and purslane, alleviated diabetic testicular dysfunction, and insulin resistance via suppression 8OHdg and oxidative stress in rats.
    PLoS One. 2024;19:e0301454.
    PubMed         Abstract available

  63. TALUKDER A, Sara SS, Hossain MT, Nath CD, et al
    Rural and urban differences in the prevalence and determinants of Type-2 diabetes in Bangladesh.
    PLoS One. 2024;19:e0298071.
    PubMed         Abstract available

  64. LERTWANICHWATTANA T, Suwannahitatorn P, Mungthin M, Rangsin R, et al
    Prognostic nomogram for uncontrolled type 2 diabetes using Thailand nation-wide cross-sectional studies.
    PLoS One. 2024;19:e0298010.
    PubMed         Abstract available

  65. ANDREES V, Bei der Kellen R, Augustin M, Gallinat J, et al
    Spatial characteristics of non-communicable diseases and their associations to social conditions in a large urban cohort in Germany-Results from the Hamburg City Health Study.
    PLoS One. 2024;19:e0301475.
    PubMed         Abstract available

  66. JANSSENS N, Van Wilder L, Van Hecke A, Van Hoorenbeeck K, et al
    COCCOS study: Developing a transition program for adolescents with chronic conditions using Experience-Based Co-Design. A study protocol.
    PLoS One. 2024;19:e0298571.
    PubMed         Abstract available

  67. ARVIDSSON D, Rodrigues Silva VR, Ekblom O, Ekblom-Bak E, et al
    Cardiorespiratory fitness and the association with galectin-1 in middle-aged individuals.
    PLoS One. 2024;19:e0301412.
    PubMed         Abstract available

  68. AGARWAL G, Lee J, Keshavarz H, Angeles R, et al
    Cardiometabolic risk factors in social housing residents: A multi-site cross-sectional survey in older adults from Ontario, Canada.
    PLoS One. 2024;19:e0301548.
    PubMed         Abstract available

  69. LEE T, Han K, Yun KI
    Association between dental scaling and metabolic syndrome and lifestyle.
    PLoS One. 2024;19:e0297545.
    PubMed         Abstract available

  70. SCHILSKY S, Green Howard A, Moore CC, Cuthbertson CC, et al
    Correlates of physical activity and sedentary behavior among cancer survivors and cancer-free women: The Women's Health Accelerometry Collaboration.
    PLoS One. 2024;19:e0301233.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  71. SHAO S, Zhang N, Specht GP, You S, et al
    Pharmacological expansion of type 2 alveolar epithelial cells promotes regenerative lower airway repair.
    Proc Natl Acad Sci U S A. 2024;121:e2400077121.
    PubMed         Abstract available


    WMJ

  72. PAPE Z, El-Alfy AT, Busse K
    Inpefa (sotagliflozin).
    WMJ. 2024;123:P1-P2.
    PubMed        


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.